Paper61124
Beta2-microglobulin on the cell surface. Specificity of inhibition of the mixed leukocyte reaction and mitogenic properties of antibodies against the two HLA antigen polypeptide chains.
Ostberg L and 2 others. Eur J Immunol, 1976. Cited by 32 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Beta2-microglobulin on the cell surface. Specificity of inhibition of the mixed leukocyte reaction and mitogenic properties of antibodies against the two HLA antigen polypeptide chains. Papers, record 61124. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/61124
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Beta2-microglobulin on the cell surface. Specificity of inhibition of the mixed leukocyte reaction and mitogenic properties of antibodies against the two HLA antigen polypeptide chains.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Beta-Globulins | Major topic |
| HLA Antigens | Major topic |
| Histocompatibility Antigens | Major topic |
| Immunity, Cellular | Major topic |
| beta 2-Microglobulin | Major topic |
| Antigen-Antibody Reactions | |
| B-Lymphocytes | |
| Humans | |
| Immunoglobulin Fab Fragments | |
| Immunoglobulin G | |
| Lymphocyte Activation | |
| Lymphocyte Culture Test, Mixed | |
| Mitogens | |
| T-Lymphocytes | |
| Time Factors |
Source PubMed
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 8,187,440 | Lymphocytotoxic antibodies in SLE: a review of the literature. | Clin Rheumatol | 1994 | https://conductscience.org/library/papers/8187440 | PubMed |
| 6,229,327 | An HLA-DR negative acute leukaemia which stimulates MLC and CMC responses. | Cancer Immunol Immunother | 1983 | https://conductscience.org/library/papers/6229327 | PubMed |
| 6,201,182 | Lack of correlation between lymphocyte activating determinants and HLA-DR on acute leukaemias. | Br J Cancer | 1984 | https://conductscience.org/library/papers/6201182 | PubMed |
| 3,977,881 | Properties and activities of aminopeptidases in normal and mitogen-stimulated human lymphocytes. | Biochem J | 1985 | https://conductscience.org/library/papers/3977881 | PubMed |
| 309,812 | B-cell activation of peripheral blood lymphocytes from patients with chronic lymphatic leukaemia. | Clin Exp Immunol | 1978 | https://conductscience.org/library/papers/309812 | PubMed |
| 89,920 | Cellular cooperation in lymphocyte activation. II. Cooperative response of human peripheral T and B lymphocytes to rabbit anti-human beta 2-microglobulin. | Clin Exp Immunol | 1979 | https://conductscience.org/library/papers/89920 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| B2M | 567 | PubTator's text mining | https://conductscience.org/library/genes/567 | NCBI Gene |
| HLA-A | 3,105 | PubTator's text mining | https://conductscience.org/library/genes/3105 | NCBI Gene |
| HLA-G | 3,135 | PubTator's text mining | https://conductscience.org/library/genes/3135 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/61124
GET https://conductscience.org/api/papers/v1/61124/authors